ClinicalTrials.Veeva

Menu

A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Not yet enrolling

Conditions

Anemia
Decreased Glomerular Filtration Rate

Treatments

Other: consultation with a specialist
Other: Usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT05735314
HSC-MS-22-0815

Details and patient eligibility

About

The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.

Enrollment

1,368 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • new, significant abnormal anemia (Hgb >1g/dl below normal, with normal white cells and platelets) or decreased estimated glomerular filtration rate (eGFR) (<60 ml/min/1.73m2 ) seen in one of the University of Texas Physicians (UTP) adult primary care clinics.

Exclusion Criteria:

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

1,368 participants in 4 patient groups

Step 1 (3 clinics) - 6 months control followed by 24 months of intervention
Experimental group
Treatment:
Other: consultation with a specialist
Other: Usual care
Step 2 (3 clinics) - 12 months control followed by 18 months of intervention
Experimental group
Treatment:
Other: consultation with a specialist
Other: Usual care
Step 3 (3 clinics) - 18 months control followed by 12 months of intervention
Experimental group
Treatment:
Other: consultation with a specialist
Other: Usual care
Step 4 (4 clinics) - 24 months control followed by 6 months of intervention
Experimental group
Treatment:
Other: consultation with a specialist
Other: Usual care

Trial contacts and locations

1

Loading...

Central trial contact

Sahar Sarfaraz; Eric Thomas, MD,MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems